Cancer Research | American Association for Cancer Research

Skip to Main Content

Advertisement

Close

AACR Journals
For Authors
About Us
Article Collections
Alerts
News
Cancer Hallmarks
Webinars

header search

search input Search input auto suggest

Search

Advanced Search

Menu

About
Articles
For Authors
Alerts
News
Cancer Hallmarks
Webinars

Skip Nav Destination

Current Issue

Volume 84,

Issue 8

15 April 2024

View This Issue

About the Journal

Cancer Research publishes impactful original studies, reviews, and opinion pieces of high significance to the broad cancer research community. Cancer Research seeks manuscripts that offer conceptual or technological advances leading to basic and translational insights into cancer biology. Read More About the Journal

Editor-in-Chief

Christine A. Iacobuzio-Donahue

View Full Editorial Board

Impact Factor

11.2

SUBMIT TO JOURNAL

Featured Articles

Fibroblasts in the Aged Pancreas Drive Pancreatic Cancer Progression

Daniel J. Zabransky, et al.

Exploiting Tertiary Lymphoid Structures to Stimulate Antitumor Immunity and Improve Immunotherapy Efficacy

Giulia Petroni; Serena Pillozzi; Lorenzo Antonuzzo

ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant Lung Cancer in Permissive Cellular Contexts

Bomiao Hu, et al.

Trending - Altmetric

The article titled, Abstract 5183: Retrospective analysis of CCNG1 expression in tumors, a novel biomarker in development for partnering with DRG-101, a tumor targeted retrovector encoding a CCNG1 inhibitor gene, has an Alt Metric Attention Score of 51. Click to see more of this article's metrics.

Read the article titled, Abstract 5183: Retrospective analysis of CCNG1 expression in tumors, a novel biomarker in development for partnering with DRG-101, a tumor targeted retrovector encoding a CCNG1 inhibitor gene

Last mentioned on Monday April 15 2024

The article titled, Abstract 5491: Targeting importin-YAP axis in pancreatic ductal adenocarcinoma, has an Alt Metric Attention Score of 196.699999999999. Click to see more of this article's metrics.

Read the article titled, Abstract 5491: Targeting importin-YAP axis in pancreatic ductal adenocarcinoma

Last mentioned on Monday April 15 2024

The article titled, Tumor cell-intrinsic p38 MAPK signaling promotes IL1⍺-mediated stromal inflammation and therapeutic resistance in pancreatic cancer., has an Alt Metric Attention Score of 10.6. Click to see more of this article's metrics.

Read the article titled, Tumor cell-intrinsic p38 MAPK signaling promotes IL1⍺-mediated stromal inflammation and therapeutic resistance in pancreatic cancer.

Last mentioned on Tuesday April 16 2024

The article titled, Abstract GS3-04: GS3-04 Capivasertib and fulvestrant for patients with aromatase inhibitor-resistant hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: results from the Phase III CAPItello-291 trial, has an Alt Metric Attention Score of 4. Click to see more of this article's metrics.

Read the article titled, Abstract GS3-04: GS3-04 Capivasertib and fulvestrant for patients with aromatase inhibitor-resistant hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: results from the Phase III CAPItello-291 trial

Last mentioned on Monday April 15 2024

The article titled, Abstract GS3-02: GS3-02 Camizestrant, a next generation oral SERD vs fulvestrant in post-menopausal women with advanced ER-positive HER2-negative breast cancer: Results of the randomized, multi-dose Phase 2 SERENA-2 trial, has an Alt Metric Attention Score of 4. Click to see more of this article's metrics.

Read the article titled, Abstract GS3-02: GS3-02 Camizestrant, a next generation oral SERD vs fulvestrant in post-menopausal women with advanced ER-positive HER2-negative breast cancer: Results of the randomized, multi-dose Phase 2 SERENA-2 trial

Last mentioned on Monday April 15 2024

Latest
Most Read
Most Cited

KDM5C-Mediated Recruitment of BRD4 to Chromatin Regulates Enhancer Activation and BET Inhibitor Sensitivity

Fibroblasts in the Aged Pancreas Drive Pancreatic Cancer Progression

Breast Cancer Stem Cells Secrete MIF to Mediate Tumor Metabolic Reprogramming That Drives Immune Evasion

TFE3-Splicing Factor Fusions Represent Functional Drivers and Druggable Targets in Translocation Renal Cell Carcinoma

The Twitter live feed is not currently active.

Keep up to date with Cancer Research

Follow @CR_AACR

Issues
Online First
Collections

News
Twitter

Online ISSN 1538-7445
Print ISSN 0008-5472

AACR Journals

Blood Cancer Discovery
Cancer Discovery
Cancer Epidemiology, Biomarkers & Prevention
Cancer Immunology Research
Cancer Prevention Research
Cancer Research
Cancer Research Communications
Clinical Cancer Research
Molecular Cancer Research
Molecular Cancer Therapeutics

Info for Advertisers
Information for Institutions/Librarians
RSS Feeds
Privacy Policy

Twitter
LinkedIn
Facebook
Youtube

Copyright © 2023 by the American Association for Cancer Research.

This Feature Is Available To Subscribers Only

Sign In or Create an Account

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.

Accept